Results 71 to 80 of about 10,503 (191)

Mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience [PDF]

open access: yes
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by a type 2 pattern of inflammation. Mepolizumab was approved for the treatment of CRSwNP in 2021. However, there is a lack of real-life studies.
Barbieri, Maria Antonietta   +18 more
core   +1 more source

Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience [PDF]

open access: hybrid, 2016
Gilda Varricchi   +5 more
openalex   +1 more source

Care pathways for the selection of a biologic in severe asthma [PDF]

open access: yes, 2017
Bousquet, Jean   +12 more
core   +2 more sources

Baseline blood eosinophil count as a predictor of treatment response to the licensed dose of mepolizumab in severe eosinophilic asthma [PDF]

open access: bronze, 2019
Frank C. Albers   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy